- Location
transplant patients
"-
OLI Has Signed a Supply Agreement with CellTrend
Dec 4, 2012One Lambda (OLI ) has signed a supply agreement with CellTrend, which allows OLI to market and distribute the Immuno-Assay product, EIA. EIA is used for Quantitative Determination of anti-Angiotensin II Receptor 1 (AT1) Antibodies. The ...
-
Thermo Fisher Scientific Has Completed Its Acquisition of One Lambda
Dec 3, 2012Thermo Fisher Scientific has completed its acquisition of One Lambda, a transplant diagnostics company. One Lambda, which had 2011 revenue of $182m, will become part of Thermo Fisher's Specialty Diagnostics Segment. Thermo Fisher ...
Tags: Thermo Fisher Scientific, One Lambda's tests, transplant patients
-
Merck Has Signed a Licensing Agreement with Aicuris for Hcmv Investigational Medicines
Nov 28, 2012Merck has signed a licensing agreement with AiCuris for the worldwide development and commercialisation rights of candidates in AiCuris' Human Cytomegalovirus (HCMV) portfolio. The HCMV portfolio includes letermovir (AIC246), an oral, ...
-
FDA Grants PMA to Roche's New Fully Automated COBAS Ampliprep Test to Quantify CMV DNA
Jul 6, 2012The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Roche's new fully automated COBAS AmpliPrep / COBAS TaqMan CMV test to quantify cytomegalovirus' (CMV) DNA in human plasma specimens. The real-time ...
Tags: Roche, FDA, Viral Load Test, PCR-based CMV test
-
One Lambda Has Entered Into Collaboration Agreement with CellTrend
Jun 18, 2012One Lambda, a provider of antibody detection assays, has entered into collaboration agreement with CellTrend. Under the agreement, CellTrend has gained rights to distribute One Lambda's Angiotensin II Receptor (AT1R) assay to improve the ...
Tags: antibody detection assays, AT1R assay, ELISA based assay
